Article
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer
30 May 2008
Abstract excerpt
BACKGROUND AND AIMS: Pancreatic cancer is among the most dismal of human malignancies. Current therapeutic strategies are virtually ineffective in controlling advanced, metastatic disease. Recent evidence suggests that the Hedgehog signalling pathway is aberrantly reactivated in the majority of pancreatic cancers, and that Hedgehog blockade has the potential to prevent disease progression and metastatic spread....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
